Screening for liver cancer: The rush to judgment

Annals of Internal Medicine

Volumn 157, Issue 4, 2012, Pages 300-301

  Sherman, Morris ^a   Bruix, Jordi ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; HIGH RISK POPULATION; HUMAN; LETTER; LIVER CANCER; LIVER CIRRHOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MASS SCREENING; NOTE; STANDARD;

CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MASS SCREENING; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84865627858     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-157-4-201208210-00021     Document Type: Letter

References (10)

1. Lederle FA, Pocha C. Screening for liver cancer: the rush to judgment. Ann Intern Med. 2012;156:387-9.
2. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020-2.
3. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:417-22.
4. Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M, et al; World Gastroenterology Organization. Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol. 2010;44:239-45.
5. European Association for the Study of the Liver. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908-43.
6. Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, et al; HCC Expert Panel of Japan Society of Hepatology. Management of hepatocellular carci- noma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis. 2011;29:339-64.
7. Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem E, et al; Asian Oncology Summit. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009;10:1111-8.
8. Poustchi H, Farrell GC, Strasser SI, Lee AU, McCaughan GW, George J. Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed? Hepatology. 2011;54: 1998-2004.
9. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology. 1995;22:432-8.
10. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47:82-9.